Home Search
eoe - search results
If you're not happy with the results, please do another search
The FASTER Act: What It Does and Why YOU Need to Help Pass It
FARE can't do it alone: Do your part to help pass the FASTER Act.
End Allergies Together, Responsible for Funding Important Research, is Winding Down Operations
"We are grateful to all of those who have supported us and helped E.A.T make such a significant impact on the food allergy industry."
Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101 in Children and...
“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
High-Tech Tissue Study Reveals Which Cells Drive a Painful Food Allergy
Findings from Cincinnati Children’s also raise questions about butyrate, a popular food supplement.
European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary Endpoint
Company Intends to Submit European MAA in Mid-2019.
Phase II Trials of AR101 with Dupilumab for Peanut Allergy to Begin
Study scheduled to commence next week.
ACAAI: Advice to Allergists Regarding Private Practice OIT
Although intended for allergists, a good read for families considering OIT as well.
Discovery Could Lead To Personalized Medical Therapies for Emerging New Food Allergy Disorder
"Our goal is to provide the type of deep disease understanding and therapeutic decision-making that is now becoming routine in the cancer field."
Facebook Tutorial: Sharing Public Articles from a Closed Food Allergy Group
A common misconception is that you can't share a great article you come across in a closed Facebook group. We explain how.
Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy
More exciting news as pharma companies work to extend the effectiveness of their therapies in combination.